Education
About Us
Working with TipRanks
Follow Us
Tatva Chintan Pharma Chem Limited (IN:TATVA)
:TATVA
Total Valuation
Tatva Chintan Pharma Chem Limited has a market cap or net worth of ₹22.16B. The enterprise value is ₹50.20B.
Market Cap₹22.16B
Enterprise Value₹50.20B
Share Statistics
Tatva Chintan Pharma Chem Limited has 23,392,056 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding23,392,056
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tatva Chintan Pharma Chem Limited’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 12.70%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)12.70%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.46
Inventory Turnover1.49
Valuation Ratios
The current PE Ratio of Tatva Chintan Pharma Chem Limited is 289.86. Tatva Chintan Pharma Chem Limited’s PEG ratio is 0.73.
PE Ratio289.86
PS Ratio0.00
PB Ratio10.49
Price to Fair Value2.24
Price to FCF-72.16
Price to Operating Cash Flow243.54
PEG Ratio0.73
Income Statement
In the last 12 months, Tatva Chintan Pharma Chem Limited had revenue of 3.83B and earned 57.13M in profits. Earnings per share was 2.44.
Revenue3.83B
Gross Profit1.84B
Operating Income1.31B
Pretax Income75.79M
Net Income57.13M
EBITDA342.13M
Earnings Per Share (EPS)2.44
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Tatva Chintan Pharma Chem Limited pays an annual dividend of ₹2, resulting in a dividend yield of 0.21%
Dividend Per Share₹2
Dividend Yield0.21%
Payout Ratio78.74%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.76
52-Week Price Change-13.79%
50-Day Moving Average807.62
200-Day Moving Average844.61
Relative Strength Index (RSI)61.62
Average Volume (3m)10.36K
Important Dates
Tatva Chintan Pharma Chem Limited upcoming earnings date is Jul 29, 2025, TBA Not Confirmed.
Last Earnings DateMay 2, 2025
Next Earnings DateJul 29, 2025
Ex-Dividend DateSep 06, 2024
Financial Position
Tatva Chintan Pharma Chem Limited as a current ratio of 2.76, with Debt / Equity ratio of 25.35%
Current Ratio2.76
Quick Ratio1.37
Debt to Market Cap0.02
Net Debt to EBITDA0.65
Interest Coverage Ratio101.44
Taxes
In the past 12 months, Tatva Chintan Pharma Chem Limited has paid 18.66M in taxes.
Income Tax18.66M
Effective Tax Rate0.25
Enterprise Valuation
Tatva Chintan Pharma Chem Limited EV to EBITDA ratio is 49.05, with an EV/FCF ratio of -32.52.
EV to Sales4.39
EV to EBITDA49.05
EV to Free Cash Flow-32.52
EV to Operating Cash Flow68.03
Balance Sheet
Tatva Chintan Pharma Chem Limited has ₹140.96M in cash and marketable securities with ₹363.88M in debt, giving a net cash position of ₹222.92M billion.
Cash & Marketable Securities₹140.96M
Total Debt₹363.88M
Net Cash₹222.92M
Net Cash Per Share₹9.53
Tangible Book Value Per Share₹313.03
Margins
Gross margin is 51.85%, with operating margin of 34.19%, and net profit margin of 1.49%.
Gross Margin51.85%
Operating Margin34.19%
Pretax Margin1.98%
Net Profit Margin1.49%
EBITDA Margin8.94%
EBIT Margin1.71%
Analyst Forecast
The average price target for Tatva Chintan Pharma Chem Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―